The Holly™ by Nephrodite device demonstrated continuous kidney function replacement in a large animal marking a critical milestone toward commercialization ATLANTA–(BUSINESS WIRE)–Nephrodite Inc., a medical device company developing an implantable, continuous dialysis system, today announced successful results from a multi-day large animal study of its Holly™ implantable renal replacement device with proprietary hemofiltration technology. Holly™ … [Read more…]

MCLEAN, Va.–(BUSINESS WIRE)–#Autism–A new, three-year analysis of autism therapy claims data by Positive Development, the leading provider of developmental therapy for autistic children and their families, shows that the company’s developmental therapy model costs 68% less, on average, per member per year, than the average cost of comparable Applied Behavior Analysis (ABA) therapy over the … [Read more…]

One of Only Five Organizations Selected Nationwide, ALAS to Pilot New Model with Stanford University School of Medicine Centered on “Cultura Cura” HALF MOON BAY, Calif.–(BUSINESS WIRE)–#alascolibriwellnessprogram–Out of more than 300 applicants, Ayudando Latinos a Soñar (ALAS) was selected as one of only five organizations in the U.S. to receive a prestigious $200,000 national research … [Read more…]

HERNDON, Va.–(BUSINESS WIRE)–As the U.S. faces a critical healthcare workforce shortage, the Heritage Valley Health System School of Nursing, part of the Pennsylvania regional healthcare provider Heritage Valley Health System, announced a new partnership with Sophia Learning, an online, on-demand, self-paced learning platform. This collaboration enables students to complete their nursing degree more efficiently by … [Read more…]

Scarcell’s Allogenic Gingival Fibroblast (aGF) Therapy First Long-Lasting Osteoarthritis Treatment to Target All Four Major Disease Effects First-Ever Use of Donor Gum Cells to Treat Osteoarthritis in Humans PARIS–(BUSINESS WIRE)–#arthritis—Scarcell Therapeutics, an innovator in cell therapies to treat chronic degenerative inflammatory diseases, today announced the world’s first patients treated with its Allogenic Gingival Fibroblast (aGF) … [Read more…]

RICHARDSON, Texas–(BUSINESS WIRE)–#agenticai—MedeAnalytics, an industry pioneer in AI-powered enterprise healthcare intelligence, analytics, and data management, and Basys.ai, an innovation leader in agentic AI for healthcare, today announced a strategic partnership designed to accelerate decision-making, reduce cost, and improve utilization management performance for all payer lines of business. MedeAnalytics brings its broad, established healthcare footprint and … [Read more…]

SYDNEY–(BUSINESS WIRE)–Box, Inc. (NYSE: BOX), the leading Intelligent Content Management (ICM) platform, today announced that the Heart Research Institute (HRI), a renowned medical research institute, selected Box to centralise and secure its research content. HRI will leverage Box to gain AI-power insights across content sources, seamlessly integrate into research applications, and maintain robust compliance features … [Read more…]

Award spotlights Dr. Mostashari’s success advancing value-based care nationwide BETHESDA, Md.–(BUSINESS WIRE)–Modern Healthcare has recognized Farzad Mostashari, MD, co-founder and CEO of Aledade, the nation’s largest network of independent value-based primary care, as one of the 100 Most Influential People in Healthcare of 2025. The publication praised Mostashari for his role in advancing value-based care … [Read more…]

Upcoming ISG Provider Lens® report will examine how providers enable digital, AI-driven transformation across the life sciences value chain STAMFORD, Conn.–(BUSINESS WIRE)–$III #CROs–Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm, has launched a research study examining IT service providers and contract research organizations (CROs) across key digital and operational … [Read more…]

BOSTON–(BUSINESS WIRE)–PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the appointment of Joseph Vittiglio, Esq., as Chief Business and Legal Officer. Mr. Vittiglio brings more than two decades of executive leadership experience across … [Read more…]